Yahoo Web Search

Search results

    • Gilead posts quarterly loss, revenue rises 5%

      Reuters· 9 minutes ago

      Gilead Sciences reported a first-quarter loss on Thursday after taking a $3.9 billion charge for its recent acquisition of liver drug developer CymaBay Therapeutics, while ...